These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 37099771

  • 1. A Retrospective Real-World Evidence Evaluation of the Characteristics of Exocrine Pancreatic Insufficiency in Patients With Chronic Pancreatitis and Type 2 Diabetes Treated With Pancrelipase in the United States.
    Rosenberg J, Reddy MN, Seelam P, Li O, Twal J, Pack J.
    Pancreas; ; 51(10):1308-1314. PubMed ID: 37099771
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of a novel pancreatic enzyme product, EUR-1008 (Zenpep), in patients with exocrine pancreatic insufficiency due to chronic pancreatitis.
    Toskes PP, Secci A, Thieroff-Ekerdt R, ZENPEP Study Group.
    Pancreas; 2011 Apr; 40(3):376-82. PubMed ID: 21343835
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
    Whitcomb DC, Lehman GA, Vasileva G, Malecka-Panas E, Gubergrits N, Shen Y, Sander-Struckmeier S, Caras S.
    Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447
    [Abstract] [Full Text] [Related]

  • 10. Retrospective analysis to investigate the effect of concomitant use of gastric acid-suppressing drugs on the efficacy and safety of pancrelipase/pancreatin (CREON®) in patients with pancreatic exocrine insufficiency.
    Sander-Struckmeier S, Beckmann K, Janssen-van Solingen G, Pollack P.
    Pancreas; 2013 Aug; 42(6):983-9. PubMed ID: 23587850
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness analysis of pancreatin minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis.
    Morawski JH, Prüfert A, van Engen A, Foerster D, Sander-Struckmeier S, Małecka-Panas E, Pezzilli R.
    J Med Econ; 2012 Aug; 15 Suppl 1():15-25. PubMed ID: 23043594
    [Abstract] [Full Text] [Related]

  • 13. The impact of pancreatic enzyme supplementation on postprandial responses of glucagon-like Peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.
    Knop FK, Vilsbøll T, Lund A, Krarup T, Holst JJ, Hornum M.
    JOP; 2010 Sep 06; 11(5):489-91. PubMed ID: 20818126
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Recurrent flares of pancreatitis predict development of exocrine insufficiency in chronic pancreatitis.
    Sandhu BS, Hackworth WA, Stevens S, Bouhaidar DS, Zfass AM, Sanyal AJ.
    Clin Gastroenterol Hepatol; 2007 Sep 06; 5(9):1085-91; quiz 1007. PubMed ID: 17588823
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pancreatic enzyme pharmacotherapy.
    Ferrone M, Raimondo M, Scolapio JS.
    Pharmacotherapy; 2007 Jun 06; 27(6):910-20. PubMed ID: 17542772
    [Abstract] [Full Text] [Related]

  • 20. Exocrine Pancreatic Insufficiency Induced by Immune Checkpoint Inhibitors.
    Satish D, Lin IH, Flory J, Gerdes H, Postow MA, Faleck DM.
    Oncologist; 2023 Dec 11; 28(12):1085-1093. PubMed ID: 37285223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.